Defined as aggressive systemic lymphomas, ALK+ALCL and ALK−ALCL are distinguishable based on genetic alterations of the ALK gene located on chromosome 2, causing the abnormal expression of ALK protein (Figure 1). This evidence concerns the gene ALK and anaplastic large cell lymphoma.